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Abbreviations 
pR, proteorhodopsin; bR, baceriorhodopsin; OG, β-octyl-D-glucoside; PMSF, 
phenylmethylsulphonyl fluoride; AMP, ampicillin; SDS-PAGE, sodium dodecyl 
sulfate polyacrylamide 
 
 
Introduction 
Proteorhodopsin (pR), a homologue of archaeal bacteriorhodopsin (bR), is a 249-
amino-acid, seven-helix, transmembrane protein bound to a retinal molecule that 
functions as a light-driven proton pump.  The retinal chromophore of pR absorbs 
a photon and isomerizes, which induces conformational changes in the protein 
structure [1].  Proteorhodopsin was discovered in the year 2000 from the DNA 
sequences of several uncultured species of marine γ-proteobacteria, which is a 
component of marine planktons present in ocean surface water [2, 3].  Since the 
discovery of pR, additional studies have found that pR is widely distributed in the 
world.  In fact, it has been projected that 10
28
 light-driven pR expressing bacteria 
exist in the world [4, 5].  Proteorhodopsin is believed to play an important role in 
the energy balance of the Earth due the large marine biomass of bacterioplanktons 
[6].   
 
Understanding the structure of pR, along with the major active site amino acid 
residues, will help us explore the important functions of this protein.  The 
majority of active site amino acid residues as well as the amino acid residues that 
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form retinal binding pockets in archaeal bacteriorhodopsin are also highly 
conserved in pR [2].  Like bacteriorhodopsin, pR has conserved arginine, 
aspartate, and lysine residues, which are important in the proton transport 
mechanism.  Specifically, the active site residues Arg
82
, Asp
85
, Asp
212
, and Lys
216
 
in bR are conserved as Arg
94
, Asp
97
, Asp
227
, and Lys
231
 in pR [7].  Furthermore, 
the retinal chromophore of pR covalently binds as a protonated Schiff’s base at 
Lys
231
, while Asp
97
 plays a significant role in proton transfer from the 
photoactivated retinal as it is the primary proton acceptor [2, 7]. 
 
The ultimate goal of this project is to form a crystallized pR in order to obtain a 
well-defined three-dimensional structure, which is essential to enhance and 
facilitate a greater understanding between the structure of pR and its function.  
Furthermore, an understanding of the purification procedures of pR could provide 
better methods for purifying and crystallizing other transmembrane proteins, in 
particular G protein-coupled receptors.  Crystallization requires a high protein 
purity of approximately 95% or greater.   
 
Proteorhodopsin had been previously purified with affinity chromatography using 
Phenylsepharose™, hydroxyapatite and/or Ni-NTA resin [8, 9].  However, the 
last technique requires pR to be cloned into the pBAD-TOPO vector with a 6xHig 
-tag at the C-terminus [2].  The use of columns also requires substantial cost and 
time, especially for purifying quantities of more than ~ 1-5 mg.  Previously, it was 
shown that proteorhodopsin (pR) is selectively precipitated using 100mM citrate 
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pH 5.5 containing 3% octyl-glucoside [6].  Applying this method, we have been 
able to precipitate pR selectively from a detergent extract of E. coli cells.  In fact, 
this method alone yields a pR purity typically approaching 32%.  The current 
experiments mainly concentrate on establishing an optimized purification pR 
yield by controlling specific conditions such as concentration, solubility, pH, and 
pR-specific precipitating agent.  Most important, we determined that phosphate 
helps with selectively precipitating the impurities from pR, and its use thereby can 
increase the purity of pR.  We systematically explored the optimal concentrations 
of phosphate, citrate, and octylglucoside to obtain with the most favorable higher 
pR purity than has ever previously been obtained without the use of column 
purification methods, i.e. in excess of 50% purity.   
 
 
Methods 
 
Enriched Luria-Bertani (LB) Media 
We added 10 g of Bacto Tryptone, 5 g of Yeast Extract, 6 g of sodium 
phosphate monobasic (NaH2PO4⋅H2O), 8.7 g of potassium phosphate dibasic 
(K2HPO4) and 10 mL of glycerol per 1-liter of distilled water into a beaker.  After 
dissolving, concentrated NaOH was used to adjust the pH to 7.  Once made, the 
solution was sterilized by autoclaving (15 min) and then stored in a cold room 
(approximately 4°C).   
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Protein Expression 
Proteorhodopsin was expressed in E. coli strain UT5600 using a pBAD TOPO 
plasmid [6].  1 mL of LB media was transferred into a small tube along with 50 
µg/mL of ampicillin.  Then, an average-size transfected E. coli colony was 
collected with a sterile pipette tip and transferred into the 1 mL of LB/Amp 
media, which was then incubated overnight at 37°C.  This starter culture was 
transferred into a flask that contains 500 mL enriched LB media containing 50 
µg/mL ampicillin.  The flask was placed in the shaker bath at 37°C for 
approximately 4-5 hours.  After 4-5 hours of growth, the heater was turned off 
and the flask was cooled quickly to room temperature, using a bucket of ice added 
to the shaker bath.  Once the temperature reached ~20°C, 1/100 volume of 20% 
L-arabionose was added, along with ~10 µg/liter of all trans-retinal dissolved in 
acetone.  The flask remained shaking (~30 rpm) in the shaker bath overnight in a 
dark room at 15-20°C.  The flask was then moved to the cold room and left 
overnight (without shaking).   
 
Cell Harvest 
The cells were collected by 30 min of centrifugation at 6000 rpm (Beckman JA-
10 rotor).  The supernatant usually immediately separated from the pellet.  We 
determined the wet weight of the pellet by taring an empty centrifuge tube, then 
weighing it along with the pellet formed by centrifugation. 
 
 5 
 
 
Cell Lysis  
The pellet was completely resuspended in approximately 5x volume of lysis 
buffer (10 mM HEPES pH 7.1 containing 1 mM PMSF protease inhibitor, 3% β-
octyl-D-glucoside, 0.08% lysozyme and 0.01 mg/mL DNAse).  The lysed cells in 
lysis buffer were centrifuged at 3900 rpm in Beckman tabletop centrifuge at 
4°C using GA-6 rotor.  The reddish colored supernatant was immediately 
separated from the pellets.  If the pellets were still colored pinkish, then the pellets 
were re-extracted in lysis buffer.  Ultimately, the grayish pellet containing 
impurities, i.e. undesired proteins, was discarded, and colored supernatants were 
combined.  This combined solution is referred to as raw detergent extract of E. 
coli.   
 
pR Purification  
1/3 volume of 100 mM sodium citrate pH 5.5 was added to the raw detergent 
extract and then left to sit for 15 minutes.  The solution was then spun down for 
15-30 minutes at 3900 rpm at 4°C.  If any white pellet was obtained at this time, 
these impurities were discarded; the colored supernatant was separated from the 
impurities, and another 1/3 volume of 100 mM sodium citrate was added to the 
colored supernatant. The centrifugation was repeated, and any colored pellets 
were saved; the supernatant was further diluted each time until the supernatant 
became nearly colorless.   All the pink-colored pellets obtained from the previous 
 6 
citrate steps were recombined by solubilizing into a minimal (~50µL) volume of 
50 mM Tris-Cl pH 9.0 containing 3% OG.  Once the pellets were completely 
resuspended, they were centrifuged (15 min, 3900 rpm).  The supernatants were 
then transferred to a new tube and any pelleted impurities were discarded.  A 
UV/Visible spectrometry measurement determined the degree of purity at this 
particular stage. 
 
The colored supernatant was then repelleted using the citrate precipitation 
methods described above.  Any remaining colored supernatant was repeatedly 
precipitated by further addition of 100 mM citrate, until all the color was 
transferred from the supernatant to pellets.  We made sure to save any colored 
pellets while removing impurities.  Once the supernatant became clear in color, 
we recombined all the colored pellets by solubilizing them into a small volume of 
50 mM Tris-Cl pH 9.0 containing 3% OG, and spun it down.  Again separating 
the pink-colored pR-containing supernatant from impurities in the colorless pellet.  
Afterwards, we saved 50 µl of pR solubilized in Tris-Cl for additional UV/Visible 
spectrometry measurements.   
 
Use of Phosphate as a Citrate competitor in Purification 
After two full cycles of citrate-induced precipitation and resolubilization in 3% 
OG Tris pH 9.0, we added 1/3 volume of 600 mM phosphate, 30 mM sodium 
citrate pH 5.5, containing 0.4% OG, and incubated for 15 minutes at room 
temperature.  Then, we spun it down for 15 minutes at 3900 rpm at 4°C.  If any 
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impurities were precipitated, they were discarded.  Then a similar volume of 30 
mM citrate/ 600 mM phosphate pH 5.5, containing 0.4% OG, was added, 
followed by centrifugation.  The addition citrate/phosphate/OG solution, followed 
by centrifugation, was repeated until the pR precipitated out of solution as a 
colored pellet.  Once a pR pellet was obtained, the supernatant was further diluted 
with 10 mM citrate pH 5.5 containing 0.4% OG alone (without phosphate), until 
the supernatant became nearly colorless.  All the colored pellets were recombined 
by solubilizing them into a small volume of 50 mM Tris-Cl pH 9.0 with 3% OG 
and was again spun down.  The pink-colored supernatant was separated and 
collected from any impurities.  50 µl of pR solubilized in Tris-Cl was saved for 
UV/Visible spectrometry measurements.  pR was reproduced from the colored 
supernatant using a combination of citrate and phosphate precipitation method 
described above.  
 
Absorption Spectroscopy 
Absorption spectra were measured on a Shimadzu UV-265 spectrophotometer at 
2nm resolution over the range 700-250 nm.  A sample volume of 0.6ml was used 
in a masked quartz micro cuvette for all measurements.  An absorbance ratio 
A280:A520 of ~2.0 indicates 100% pure pR, as shown previously [9]. 
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Result and Discussion 
Purification of pR with Citrate Precipitation 
 
Figure 1.  UV/Visible Absorption Spectra of pR in 50 mM Tris-Cl pH 9.1 containing 3% 
octylglucoside solution at three rounds of purification.  All spectra were measured in the 
presence of OG at pH 9.1.   Green Spectra indicates the preliminary purification of pR using 100 
mM citrate pH 5.5; Purple Spectra indicates the second round of the same method; Red, spectra 
for the first pellet treated with 30 mM citrate pH 5.5 resuspended in Tris; Blue, the same method – 
30 mM citrate pH 5.5 – was applied. 
 
As shown in Figure 1, the preliminary purification of pR using 100 mM citrate pH 
5.5 yielded approximately 11:1 ratio of A280:A520.  The same method of 
purification with 100 mM citrate was repeated for the second round resulting in 
approximately 6:1 absorbance ratio.  Within two rounds of 100 mM citrate 
precipitation, we were able to purify pR and reduce the ratio from 11:1 to 6:1.  
After two full cycles of citrate, pR was treated with 30 mM citrate pH 5.5 
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containing 0.4% OG, in which we measured the UV spectra of pellets separately, 
instead of combining them, at each addition of citrate.  The ratio of the first pellet 
in Tris was nearly 3:1 while the second pellet in Tris was 4:1 (Figure 1).  The 
color of pellets at this stage was very bright with high intensity in pR pellets.  The 
result indicates that a high concentration of citrate already had precipitated the 
impurities as well as other undesired proteins by citrate binding to numerous 
proteins.  The color also indicates that pR has one or more binding sites for 
citrate; thus, a lower concentration of citrate is enough to specifically bind pR to 
precipitate more effectively once the impurities are removed.  
 
Finding a Better Concentration of Citrate in the Presence of 600mM Phosphate  
After a few rounds of citrate precipitation including both 100 mM concentration 
and a lower concentration, pR was treated with 30 mM citrate and 600 mM 
phosphate pH 5.5 containing 0.4% OG.  This particular concentration of 
phosphate along with citrate brings down more impurities, while leaving pR 
solubilitzed.  We believe that phosphate prevents precipitation by competing for 
the citrate binding site, thereby blocking citrate-induced aggregation.  This 
particular method could be a good transition in purification as it removes more 
impurities and increases the purity of pR.  In the presence at constant 600 mM 
concentration of phosphate, we attempted to explore a better concentration of 
citrate.  The goal was to find the lowest citrate concentration that can induce 
aggregation in the presence of phosphate.   
 10
 
Figure 2.  UV/Visible Absorption Spectra of pR resuspended in Tris-Cl pH 9.1 with 3% OG 
after treated with different concentrations of citrate at pH 5.5 while have the same 600 mM 
phosphate present.  Purple Spectra indicates pR treated with 65 mM citrate; Green, 30 mM 
citrate; Red, 15 mM citrate. 
 
We tested three different citrate concentrations – 65 mM, 30 mM and 15 mM – at 
pH 5.5 with the presence of 600 mM phosphate.  Among different concentrations, 
the ratio of A280:A520 of 30 mM citrate along with 600 mM phosphate gave 
approximately 3:1, one of the best purity levels we have ever obtained in the 
laboratory without columns, while 65 mM and 15 mM both yielded 
approximately 4:1 ratio (Figure 2).  It was interesting to note that 30 mM, which 
is neither the lowest nor the highest concentration of citrate, could bring down the 
pR to the highest purity level so far achieved.   
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Based on these results we investigated the most favorable conditions that would 
increase the degree of purity of pR and have the ability to recover pR in high 
yield.  We examined several different ways of purification of pR after a few 
rounds of purification steps with both 100 mM and 30 mM citrate pH 5.5.   
 
Use of Phosphate in pR Purification 
We tried using 600 mM phosphate with 30 mM citrate pH 5.5 containing 0.4% 
OG, only without switching back to citrate alone after 2-3 citrate precipitation 
rounds.  Using a mixture of citrate and phosphate, we were able to remove more 
impurities, and then precipitated pR.  The pellets were resuspended in Tris for the 
UV spectra measurements.  The first pellet in Tris resulted approximately 7:1 
ratio of purity, whereas a ratio of the second and third pellets in Tris diminished to 
4:1 and 3:1 respectively (Figure 3).  As more volume of phosphate along with 
citrate was added, we were able to obtain purer pellets.  However, one problem 
that occurred in this particular method was that it was difficult to recover the pR 
completely, meaning there was still color left in the supernatant and we were not 
able to completely bring the color down into a pellet.  This might suggest that 600 
mM phosphate may be too high in pR precipitation, as the binding sites may have 
been occupied by phosphate; thus, phosphate blocks citrate-induced aggregation. 
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Figure 3.  UV/Visible Absorption Spectra of pR in 50 mM Tris-Cl pH 9.1 containing 3% OG 
at 30 mM citrate and 600 mM phosphate pH 5.5 w/ 0.4% OG purification.  Blue, first 
precipitated pR pellet in Tris; Green, second pR pellet obtained; Red, third precipitation of pR 
pellet resuspended in Tris for spectrum.  There was still color left in the supernatant even after 
third precipitation and could not complete reproducing pR.   
 
Use of a Lower Concentration of Citrate Alone 
After the preliminary citrate precipitation procedures including both 100 mM and 
30 mM citrate at pH 5.5, we tried an even lower concentration of citrate, 10 mM 
citrate pH 5.5 containing 0.4% OG, in a small amount of pR in Tris and repeated 
the same addition/centrifugation procedure steps.  The low concentration of 
citrate precipitation without any phosphate maintained approximately a 4:1 ratio 
of pR purity at the first addition of 10 mM citrate.  In the second addition, we 
brought all the color down from the solution into a pellet; the purity of the pellet 
was increased to 6:1 due to a precipitation of pR, even with other undesired 
proteins (Figure 4).    
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Figure 4.  UV Spectra of pR resuspended in Tris-Cl pH 9.1 w/ 3% OG after 10 mM citrate 
pH 5.5 containing 0.4% precipitation.  Red, first precipitation; Purple, second precipitation of 
pR that had precipitated all color into a pallet from the supernatant. 
 
Alternating Treatment with Citrate Alone and with both Citrate and Phosphate 
The results from applications of 30 mM citrate and 600 mM phosphate and 10 
mM citrate alone has led us to treat pR with 30 mM citrate and 600 mM 
phosphate pH 5.5 contaning 0.4% OG first after the preliminary citrate 
precipitation, and then switching to 10 mM citrate pH 5.5 containing 0.4% OG, 
and vice versa.  
pR that was initially treated with a mixture of citrate and phosphate resulted in 
approximately 7:1 A280:A520 ratio.  Once the first pR pellet was obtained from 
citrate and phosphate solution, we treated pR with 10 mM citrate alone without 
having phosphate in the solution.  The second pellet obtained from addition of 10 
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mM citrate pH 5.5 containing 0.4% OG reduced the purity down to 5:1.  Finally, 
the third pR pellet treated with 10 mM citrate pH 5.5 was the last pellet 
precipitated, which brought all the color from the supernatant down; the purity of 
third pR pellet decreased as the ratio rose to 6:1 ratio of purity (Figure 5). 
 
 
Figure 5.  UV spectra of pR, which was initially treated with 30 mM citrate along with 600 
mM phosphate then switched to 10 mM citrate alone, resuspended in 50 mM Tris-Cl pH 9.1 
containing 3% OG.  Red, spectra of pR precipitated from use of citrate and phosphate; Green, pR 
pellet precipitated from 10 mM citrate after switched from citrate and phosphate solution; Purple, 
second pR pellet obtained from 10 mM citrate precipitation.  
 
Moreover, we tried reversing the order of steps.  We initially treated with 10 mM 
citrate pH 5.5 containing 0.4% OG, and then switched to 30 mM citrate and 600 
mM phosphate pH 5.5 with 0.4% OG.  This method was problematic because it 
was difficult to precipitate pR completely in the presence of phosphate.  We tested 
the idea of raising the concentration of citrate, which would allow to compete 
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with phosphate as it would precipitate pR.  The difficulty in recovering pR was 
finally solved by gradually reducing the citrate and phosphate concentrations, 
while keeping OG concentration constant.  We added 400 mM citrate and 600 
mM phosphate pH 5.5 containing 0.4% OG.  Then we added an equal volume of 
0.4% OG solution itself and let it sit over a long period of time (~10 days).  The 
constant OG concentration, with a high concentration of citrate, selectively 
precipitated pR.  The UV absorption spectrum indicated that the ratio of purity 
was nearly 5:2, which was the best result obtained to date (Figure 6), and likely 
indicative of a final pR purity level of ~50% of protein by weight.   
Overall, the use of phosphate along with citrate is promising in pR purification.  
This particular purification procedure has brought us a step closer in achieving 
crystallization through efficient use of inexpensive materials.   
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Figure 6.  UV/Visible Spectrum of pR, which has been precipitated from 400 mM citrate and 
600 mM phosphate pH 5.5 containing >0.4% OG, dissolved in 50 mM Tris-Cl pH 9.1 w/ 3% 
OG.  The spectrum indicates a purity of pR after the pR purification in alternating 10 mM citrate 
pH 5.5 w/ 0.4% OG and 400 mM citrate and 600 mM phosphate pH 5.5 w/ > 0.4% OG.  
 
Phosphate and pKa value 
During this whole project, I have noticed one very interesting result.  When I 
added 30 mM citrate and 600 mM phosphate pH 5.5 containing 0.4% OG into pR 
resuspended in 50mM Tris-Cl pH 9.1 with 3% OG, the color clearly changes from 
reddish to purple (Figure 7). 
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Figure 7.  The color shift in pR depends on the presence of phosphate.  Left, 10 mM citrate pH 
5.5 containing 0.4% OG added into pR dissolved in 50 mM Tris-Cl pH 9.1 containing 3% OG; 
Right, 30 mM citrate and 600 mM phosphate pH 5.5 containing 0.4% OG added into pR 
resuspended in 50 mM Tris-Cl pH 9.1 containing 3% OG. 
 
 
That is, the color of pR is red at basic pH (Tris-Cl pH 9.1 containing 3% OG).  
When we added citrate, pH 5.5 to such a pH 9 solution, there was no notable 
change in the color of pR.  However, a different result was obtained when 30 mM 
citrate and 600 mM phosphate pH 5.5 was added into the same pR sample, 
originally at pH 9.  When the mixture of citrate and phosphate was added into pR, 
the color consistently turned into an intense purple and was clearly 
distinguishable from the color of pR that was phosphate-free though they were at 
similar pH levels (Figure 8 Left).  Then, subsequent switching of the solutions, 
i.e. addition of phosphate into the solution that originally had citrate only, yielded 
the same intense purple color (Figure 8 Right).  This indicates that phosphate 
could raise the pKa value of pR, which is due to the titration of Asp
97
 the 
chromophore’s counter ion. 
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Figure 8.  Comparison in color of pR with the presence of phosphate and without phosphate.  
Left, 10 mM citrate pH 5.5 containing 0.4% OG is added into pR dissolved in 50 mM Tris-Cl pH 
9.1 w/ 0.4% OG on the left, whereas 30 mM citrate and 600 mM phosphate pH 5.5 containg 0.4% 
OG is added into pR dissolved in Tris on the right; Right, a solution of citrate and phosphate is 
added into pR on the left while 10 mM citrate is added into pR instead of a mixture of phosphate 
and citrate on the right. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 19
References 
 
[1] Fuhrman JA, Schwalbach MS, Stingl U.  Proteorhodopsins: an array of 
physiological roles? Nat Rev Microbiol. 2008 Jun; 6(6): 488-94. 
 
[2] Béjà O, Aravind L, Koonin EV, Suzuki MT, Hadd A, Nguyen LP, Jovanovich 
SB, Gates CM, Feldman RA, Spudich JL, Spudich EN, DeLong EF.  Bacterial 
rhodopsin: Evidence for a new type of phototrophy in the sea.  Science. 2000; 
289: 1902-1906. 
 
[3] Béjà O, Spudich EN, Spudich JL, Leclerc M, DeLong EF.  Proteorhodopsin 
Phototrophy in the Ocean.  Nature. 2001; 411:786-789. 
 
[4] Morris RM, Rappé MS, Connon SA, Vergin KL, Siebold WA, Carlson CA, 
Giovannoni SJ.  SAR11 clade dominates ocean surface bacterioplankton 
communities.  Nature. 2002 Dec 19-26; 420:806. 
 
[5] Walter JM, Greenfield D, Bustamante C, Liphardt J.  Light-powering 
Escherichia coli with proteorhodopsin.  PNAS. 2007 Feb 13; 104(7): 2408-
2412.  
 
[6] R. Partha, M.S. Braiman.  A rapid and inexpensive method for the 
purification of proteorhodopsin.  U.S. Provisional Patent Application 60/485, 
272 (2003). 
 
[7] Partha R, Krebs R, Caterino TL, Braiman MS.  Weakened coupling of 
conserved arginine to the proteorhodopsin chromophore and its counterion 
implies structural differences from bacteriorhodopsin.  Biochimica Biophysica 
Acta. 2005 Jun 1; 1708(1): 6-12. 
 
[8] Dioumaev et al.  Proton Transfers in the Photochemical Reaction Cycle of 
Proteorhodopsin.  Biochemistry, 2002; 41:5348-5358. 
 
[9] R. Krebs, U. Alexiev, R. Partha, A.M. DeVita and M.S. Braiman.  Detection 
of Fast Light-Activated H+ Release and M Intermediate Formation from 
Proteorhodopsin.  BMC Physiol., 2002; 2:1-8. 
 
 
 
 
 
 
 20
Summary 
 
Proteorhodopsin (pR) is a transmembrane protein bound to a retinal molecule that 
function as light-driven proton pump.  In other words, when proteorhodopsin is 
bound to a retinal molecule and is exposed to light, a conformational change 
occurs as it generates energy.  Retinal is a derivative of vitamin A.  
Proteorhodsopin is believed to serve as a possible alternative energy source that 
could play an important role in the energy balance of the Earth.  Proteorhodopsin 
is widely distributed, and the bacteria containing it are some of the most prevalent 
organisms on Earth.  Proteorhodopsin has many potential uses and benefits in 
commercial biotechnological applications and other industries.  Also, 
understanding the roles of pR in the oceanic food chain might help us to study 
some significant impacts of global changes on marine communities and in the 
ecosystem. 
 
Unfortunately, ever since this particular protein has been discovered in 2000, it 
has been difficult and challenging to obtain a well-defined three-dimensional 
structure.  Knowing the 3-D crystal structure of proteorhodopsin would 
tremendously enhance a greater understanding in its functions and specific 
physiological roles. 
 
In order to obtain a well-defined three-dimensional structure, we have to form a 
crystallized pR to perform x-ray crystallography – a method of determining the 
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arrangement of atoms within a crystal – and crystallization requires a high pR 
purity approximately 95% or greater.   
 
Therefore, this project focused on establishing an optimized purification pR yield 
by controlling specific conditions such as concentration, solubility, pH, and pR-
specific precipitating agents.  An understanding of the purification procedures of 
proteorhodopsin could provide a better understanding in other various 
transmembrane proteins, in particular the G protein-coupled receptors, which 
constitute a large protein family of seven transmembrane receptors that activate 
signal transduction pathways and cellular responses to pharmaceuticals. 
 
Proteorhodopsin had been previously purified with columns and with other 
materials that require both time and high cost.  Professor Braiman and his 
laboratory developed and established an invention for purifying pR using a simple 
salt, sodium citrate, to precipitate pR selectively from a detergent extract of E. 
coli cells.  This particular method gave approximately 20-30% purity in a single 
step, and is suitable for the preliminary purification. 
 
In this project, we continued to explore a method that would increase the purity as 
well as have the ability to reproduce a large quantity of pR.  We expected that 
another simple salt, phosphate, could help with selectively precipitating the 
impurities from pR, which may increase the purity of pR.  We have obtained 
evidence that alternating treatment between citrate alone, and with citrate along 
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with phosphate, may be a useful set of purification steps throughout this project. 
The pR obtained from this purification procedure using citrate and phosphate 
yields adequate quantity and purity of proteins that are suitable in techniques such 
as SDS-PAGE (sodium dodecylsulfate polyacrylamide gel electrophoresis) and 
UV/Visible absorption spectrum.  This purification procedure of proteorhodopsin 
is simple; it includes adding solution then centrifugation in order to selectively 
precipitate impurities or pR.  Purple pellets contain pR, and should be saved for 
UV/Visible Spectroscopy for the examination of the degree of pR purity. The 
advantage of using citrate and phosphate in pR purification is that they are 
inexpensive materials, which reduce cost tremendously as it eliminates the use of 
a column, but still has the ability to provide the same level of purity.  This simple 
purification method to purify pR proved less costly and more efficient.  Also, this 
method could possibly purify other transmembrane proteins (G protein-coupled 
receptors), which would be enormously significant for pharmaceutical purposes. 
 
This project should be continued to seek better conditions that would increase the 
quantity of pR as well as purity.  The pR purification procedure described in the 
Capstone Project has shown potential, but needs further work.  The ultimate goal 
of the project is a well-defined three-dimensional structure of proteorhodopsin 
and this work has brought us a step closer in achieving crystallization through 
citrate and phosphate precipitation of pR.   
 
